I think link to PR is a problem , try here..
Post# of 154540
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors :: CytoDyn Inc. (CYDY)
OK here is also a problem , anyway PR from May 13 , 2025,
Last sentence of last paragraph Dr Jay is talking to add PD-L1 testing in CRC.

